Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Gynecology

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 176 articles:
HTML format



Single Articles


    July 2021
  1. WARASNA B, Rajabi N, Mustafa B, Najjar A, et al
    Knowledge and attitude of Palestinian women to contraceptives: a cross-sectional study.
    Lancet. 2021;398 Suppl 1:S45.
    PubMed     Abstract available


  2. ISBEIH M, Venkateswaran M, Abbas E, Abu-Khader K, et al
    Gestational age recorded at delivery versus estimations using antenatal care data from the Electronic Maternal and Child Health Registry in the West Bank: a comparative analysis.
    Lancet. 2021;398 Suppl 1:S31.
    PubMed     Abstract available


  3. EL-QATRAWI KJ
    Effect of hypertension on pregnancy outcomes at UNRWA health centres in Gaza governorates: a comparative study.
    Lancet. 2021;398 Suppl 1:S26.
    PubMed     Abstract available


  4. BOGALE B, Morkrid K, O'Donnell B, Ghanem B, et al
    Development of a targeted client communication intervention for pregnant and post-partum women: a descriptive study.
    Lancet. 2021;398 Suppl 1:S18.
    PubMed     Abstract available


    May 2021
  5. CHAPPELL LC, Cluver CA, Kingdom J, Tong S, et al
    Pre-eclampsia.
    Lancet. 2021 May 27. pii: S0140-6736(20)32335.
    PubMed     Abstract available


  6. MENON U, Gentry-Maharaj A, Burnell M, Singh N, et al
    Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
    Lancet. 2021 May 12. pii: S0140-6736(21)00731.
    PubMed     Abstract available


  7. HURWITZ LM, Pinsky PF, Trabert B
    General population screening for ovarian cancer.
    Lancet. 2021 May 12. pii: S0140-6736(21)01061.
    PubMed    


    April 2021
  8. THE LANCET
    Miscarriage: worldwide reform of care is needed.
    Lancet. 2021 Apr 26. pii: S0140-6736(21)00954.
    PubMed    


  9. COOMARASAMY A, Dhillon-Smith RK, Papadopoulou A, Al-Memar M, et al
    Recurrent miscarriage: evidence to accelerate action.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00681.
    PubMed     Abstract available


  10. COOMARASAMY A, Gallos ID, Papadopoulou A, Dhillon-Smith RK, et al
    Sporadic miscarriage: evidence to provide effective care.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00683.
    PubMed     Abstract available


  11. QUENBY S, Gallos ID, Dhillon-Smith RK, Podesek M, et al
    Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00682.
    PubMed     Abstract available


  12. KADIWAR S, Smith JJ, Ledot S, Johnson M, et al
    Were pregnant women more affected by COVID-19 in the second wave of the pandemic?
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00716.
    PubMed    


  13. LOCKMAN S, Brummel SS, Ziemba L, Stranix-Chibanda L, et al
    Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAA
    Lancet. 2021;397:1276-1292.
    PubMed     Abstract available


  14. GILLEECE Y, Krankowska D
    ART in pregnant women living with HIV.
    Lancet. 2021;397:1240-1241.
    PubMed    


    February 2021
  15. TAYLOR HS, Kotlyar AM, Flores VA
    Endometriosis is a chronic systemic disease: clinical challenges and novel innovations.
    Lancet. 2021;397:839-852.
    PubMed     Abstract available


    January 2021
  16. BOOTH A
    Honduras changes constitution to ban abortion.
    Lancet. 2021;397:360.
    PubMed    


  17. LHEUREUX S, Cristea MC, Bruce JP, Garg S, et al
    Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Lancet. 2021;397:281-292.
    PubMed     Abstract available


  18. BLAGDEN SP, Nicum S
    A source of hope for platinum-resistant ovarian cancer?
    Lancet. 2021;397:254-256.
    PubMed    


  19. BOOTH A
    Argentina to legalise elective abortion.
    Lancet. 2021;397:82.
    PubMed    


    December 2020
  20. CLARKE C
    Abortion and The Lancet's call to arms.
    Lancet. 2020;394:2241.
    PubMed    


    November 2020
  21. GILBERT L, Miller K, Medeiros D, Tsatoumas M, et al
    A disease disregards anatomical planes: actinomycosis and an intrauterine device.
    Lancet. 2020;396:1766.
    PubMed    


  22. CAMERON ST, Glasier A, McDaid L, Radley A, et al
    Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trial.
    Lancet. 2020;396:1585-1594.
    PubMed     Abstract available


  23. MARSTON C, Sowemimo A
    Bridge-It trial-a step towards better contraception services.
    Lancet. 2020;396:1536-1537.
    PubMed    


    September 2020
  24. ALVES L
    Brazilian doctors condemn new rules on abortion.
    Lancet. 2020;396:808.
    PubMed    


  25. SHAHAR-NISSAN K, Pardo J, Peled O, Krause I, et al
    Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020;396:779-785.
    PubMed     Abstract available


  26. LEVY L, Meuwly JY, Sarivalasis A, Achtari C, et al
    Survival of the fetus: cervical cancer and pregnancy, a challenging combination.
    Lancet. 2020;396:725.
    PubMed    


  27. EVANS DK, Acosta AM
    Lifting bans on pregnant girls in school.
    Lancet. 2020;396:667-668.
    PubMed    


    August 2020
  28. DASHRAATH P, Nielsen-Saines K, Madhi SA, Baud D, et al
    COVID-19 vaccines and neglected pregnancy.
    Lancet. 2020 Aug 27. pii: S0140-6736(20)31822.
    PubMed    


  29. CHU JJ, Devall AJ, Beeson LE, Hardy P, et al
    Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020 Aug 24. pii: S0140-6736(20)31788.
    PubMed     Abstract available


  30. BARNHART K
    Medical management of miscarriage with mifepristone.
    Lancet. 2020 Aug 24. pii: S0140-6736(20)31789.
    PubMed    


  31. VON DADELSZEN P, Bhutta ZA, Sharma S, Bone J, et al
    The Community-Level Interventions for Pre-eclampsia (CLIP) cluster randomised trials in Mozambique, Pakistan, and India: an individual participant-level meta-analysis.
    Lancet. 2020;396:553-563.
    PubMed     Abstract available


  32. POUCHOT J, Couprie A
    A wandering spleen, splenomegaly, hypersplenism, and iron deficiency anaemia.
    Lancet. 2020;396:412.
    PubMed    


  33. CROVETTO F, Crispi F, Llurba E, Figueras F, et al
    Seroprevalence and presentation of SARS-CoV-2 in pregnancy.
    Lancet. 2020 Aug 6. pii: S0140-6736(20)31714.
    PubMed    


  34. MAEDA Y, Ogawa K, Kamihara Y, Tanimoto T, et al
    Managing late preterm pre-eclampsia.
    Lancet. 2020;396:308.
    PubMed    


  35. CHAPPELL LC, Juszczak E, Shennan A
    Managing late preterm pre-eclampsia - Authors' reply.
    Lancet. 2020;396:308-309.
    PubMed    


  36. CARBILLON L
    Managing late preterm pre-eclampsia.
    Lancet. 2020;396:307-308.
    PubMed    


    July 2020
  37. JAFFE S
    US Supreme Court upholds abortion rights, for now.
    Lancet. 2020;396:85-86.
    PubMed    


  38. CLUVER CA, Herbst P, Griffith-Richards S, Hassan M, et al
    Coarctation of the aorta: a rare cause of severe hypertension in pregnancy.
    Lancet. 2020;396:62.
    PubMed    


  39. MCGOVERN T
    US Global Gag Rule increases unsafe abortion.
    Lancet. 2020;396:24-25.
    PubMed    


  40. GINSBURG O, Horton R
    A Lancet Commission on women and cancer.
    Lancet. 2020;396:11-13.
    PubMed    


    June 2020
  41. ALLEN S, Cortina CS
    An unusual cause of breast hypertrophy: pseudoangiomatous stromal hyperplasia secondary to contraceptive implant.
    Lancet. 2020;395:1937.
    PubMed    


  42. LADHANI SN, Lucidarme J, Parikh SR, Campbell H, et al
    Meningococcal disease and sexual transmission: urogenital and anorectal infections and invasive disease due to Neisseria meningitidis.
    Lancet. 2020;395:1865-1877.
    PubMed     Abstract available


    May 2020
  43. WHITEHEAD CL, Walker SP
    Consider pregnancy in COVID-19 therapeutic drug and vaccine trials.
    Lancet. 2020 May 13. pii: S0140-6736(20)31029.
    PubMed    


    April 2020
  44. PANCHAUD A, Favre G, Pomar L, Vouga M, et al
    An international registry for emergent pathogens and pregnancy.
    Lancet. 2020 Apr 27. pii: S0140-6736(20)30981.
    PubMed    


    March 2020
  45. CHEN H, Guo J, Wang C, Luo F, et al
    Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.
    Lancet. 2020;395:809-815.
    PubMed     Abstract available


  46. QIAO J
    What are the risks of COVID-19 infection in pregnant women?
    Lancet. 2020;395:760-762.
    PubMed    


  47. MCGREADY R, Nosten F, Barnes KI, Mokuolu O, et al
    Why is WHO failing women with falciparum malaria in the first trimester of pregnancy?
    Lancet. 2020;395:779.
    PubMed    


    February 2020
  48. BURKI T
    UNAIDS and IAEA join forces on HIV and cervical cancer.
    Lancet. 2020;395:484.
    PubMed    


  49. THE LANCET
    Appropriate care for pregnant women in Ebola outbreaks.
    Lancet. 2020;395:468.
    PubMed    


  50. THE LANCET
    Preventing teenage pregnancies in Brazil.
    Lancet. 2020;395:468.
    PubMed    


  51. TANIGUCHI Y, Nishikawa H, Maeda N, Terada Y, et al
    Breathlessness, pleural effusions, fibromas, and Meigs syndrome: look beyond the chest and don't delay!
    Lancet. 2020;395:e32.
    PubMed    


  52. FAVRE G, Pomar L, Musso D, Baud D, et al
    2019-nCoV epidemic: what about pregnancies?
    Lancet. 2020 Feb 6. pii: S0140-6736(20)30311.
    PubMed    


  53. THE LANCET
    Eliminating cervical cancer.
    Lancet. 2020;395:312.
    PubMed    


  54. UZOIGWE CE
    No global consensus among doctors or society on abortion.
    Lancet. 2020;395:e17.
    PubMed    


  55. DUHIG K, Myers J, Seed PT, Shennan AH, et al
    Placental growth factor testing in suspected pre-eclampsia - Authors' reply.
    Lancet. 2020;395:336-337.
    PubMed    


  56. KERMACK AJ, Stocker LJ, Coleman M
    Placental growth factor testing in suspected pre-eclampsia.
    Lancet. 2020;395:335-336.
    PubMed    


  57. TANNER M, Mol BW
    Placental growth factor testing in suspected pre-eclampsia.
    Lancet. 2020;395:335.
    PubMed    


  58. PHUMAPHI J, Gautam KC, Mason E
    Increased production and comprehensive guidelines needed for HPV vaccine.
    Lancet. 2020;395:319-321.
    PubMed    


    January 2020
  59. CANFELL K, Kim JJ, Brisson M, Keane A, et al
    Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30157.
    PubMed     Abstract available


  60. BRISSON M, Kim JJ, Canfell K, Drolet M, et al
    Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30068.
    PubMed     Abstract available


  61. TSU VD
    Cervical cancer elimination: are targets useful?
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30219.
    PubMed    


  62. HOFFMAN MK, Goudar SS, Kodkany BS, Metgud M, et al
    Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020;395:285-293.
    PubMed     Abstract available


  63. FOWKES FJI, Davidson E, Moore KA, McGready R, et al
    The invisible burden of malaria-attributable stillbirths.
    Lancet. 2020;395:268.
    PubMed    


  64. GETHING P, Hay S, Weiss D
    The invisible burden of malaria-attributable stillbirths - Authors' reply.
    Lancet. 2020;395:268-269.
    PubMed    


    November 2019
  65. LYERLY AD
    Dolutegravir: advancing ethical research in pregnancy.
    Lancet. 2019;394:1972-1974.
    PubMed    


  66. CLAMP AR, James EC, McNeish IA, Dean A, et al
    Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
    Lancet. 2019 Nov 29. pii: S0140-6736(19)32259.
    PubMed     Abstract available


  67. ESKANDER RN, Monk BJ
    Moving beyond cytotoxic drug dosing in ovarian cancer.
    Lancet. 2019 Nov 29. pii: S0140-6736(19)32948.
    PubMed    


  68. CERDEIRA AS, Tome M, Moore N, Lim L, et al
    Seeing red degeneration in uterine fibroids in pregnancy: proceed with caution.
    Lancet. 2019;394:e37.
    PubMed    


    October 2019
  69. O'NEILL D
    Abortion as a moral good?
    Lancet. 2019;394:1323-1324.
    PubMed    


  70. MILLER D
    Hyaluronan-selected sperm should not be considered an add-on - Author's reply.
    Lancet. 2019;394:1320.
    PubMed    


  71. PARMEGIANI L
    Hyaluronan-selected sperm should not be considered an add-on.
    Lancet. 2019;394:1319-1320.
    PubMed    


    September 2019
  72. SUGIMURA K, Sasaki O, Shinoda M, Kawasaki S, et al
    Catamenial pneumothorax: a cause of monthly breathlessness.
    Lancet. 2019;394:952.
    PubMed    


  73. SINGH S, Bougie O
    HEALTH for heavy menstrual bleeding: real-world implications.
    Lancet. 2019 Sep 12. pii: S0140-6736(19)32086.
    PubMed    


  74. COOPER K, Breeman S, Scott NW, Scotland G, et al
    Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial.
    Lancet. 2019 Sep 12. pii: S0140-6736(19)31790.
    PubMed     Abstract available


    August 2019
  75. KOTSOPOULOS J
    Menopausal hormones: definitive evidence for breast cancer.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)31901.
    PubMed    



  76. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)31709.
    PubMed     Abstract available


  77. BERAL V, Peto R, Pirie K, Reeves G, et al
    Menopausal hormone therapy and 20-year breast cancer mortality.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)32033.
    PubMed    


  78. CHAPPELL LC, Brocklehurst P, Green ME, Hunter R, et al
    Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial.
    Lancet. 2019 Aug 28. pii: S0140-6736(19)31963.
    PubMed     Abstract available


  79. STAFF AC
    Long-term cardiovascular health after stopping pre-eclampsia.
    Lancet. 2019 Aug 28. pii: S0140-6736(19)31993.
    PubMed    


  80. LAWRIE TA
    Prepregnancy calcium supplementation and pre-eclampsia - Author's reply.
    Lancet. 2019;394:e8.
    PubMed    


  81. MAEDA Y, Suzuki Y, Yamamoto K, Tanimoto T, et al
    Prepregnancy calcium supplementation and pre-eclampsia.
    Lancet. 2019;394:e7.
    PubMed    


  82. PONZETTO A, Figura N, Riva P
    Prepregnancy calcium supplementation and pre-eclampsia.
    Lancet. 2019;394:e6.
    PubMed    


  83. HAIGH A, Haigh K
    Coroners' investigations of stillbirths.
    Lancet. 2019;394:564.
    PubMed    


  84. LEMOINE ER, Karumanchi SA
    Oral regimen management of acute hypertension in pregnancy.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31717.
    PubMed    


  85. CHAPPELL LC, Bell JL, Smith A, Linsell L, et al
    Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31270.
    PubMed     Abstract available


  86. EASTERLING T, Mundle S, Bracken H, Parvekar S, et al
    Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31282.
    PubMed     Abstract available


  87. MARSCHALL HU
    Ursodeoxycholic acid for intrahepatic cholestasis in pregnancy.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31607.
    PubMed    


    July 2019
  88. BURKI T
    Northern Ireland likely to legalise abortion.
    Lancet. 2019;394:290.
    PubMed    


  89. HEMIDA R, van Doorn HC
    Avoid making a mountain out of an invasive hydatidiform mole: do a pregnancy test!
    Lancet. 2019;394:e2.
    PubMed    


  90. CHATTERJEE P
    Hysterectomies in Beed district raise questions for India.
    Lancet. 2019;394:202.
    PubMed    


    June 2019
  91. DE SANJOSE S, Delany-Moretlwe S
    HPV vaccines can be the hallmark of cancer prevention.
    Lancet. 2019 Jun 26. pii: S0140-6736(19)30549.
    PubMed    


  92. DROLET M, Benard E, Perez N, Brisson M, et al
    Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
    Lancet. 2019 Jun 26. pii: S0140-6736(19)30298.
    PubMed     Abstract available


  93. SMIT JG
    Ongoing pregnancy as the primary outcome for the inSIGHT study.
    Lancet. 2019;393:2389.
    PubMed    



  94. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
    Lancet. 2019 Jun 13. pii: S0140-6736(19)31288.
    PubMed     Abstract available


    May 2019
  95. THE LANCET
    We must all support women in the fight for abortion.
    Lancet. 2019;393:2099.
    PubMed    


  96. JAFFE S
    Legal battles over abortion heat up in the USA.
    Lancet. 2019;393:1923-1924.
    PubMed    


  97. LI A
    Northern Ireland deadlock impedes abortion rights progress.
    Lancet. 2019;393:1794.
    PubMed    


  98. BUJOLD E, Chaillet N, Kingdom J
    Placental growth factor testing for suspected pre-eclampsia.
    Lancet. 2019;393:1775-1776.
    PubMed    


  99. KIRKCALDY RD, Workowski KA
    Gentamicin as an alternative treatment for gonorrhoea.
    Lancet. 2019 May 2. pii: S0140-6736(19)30244.
    PubMed    


  100. ROSS JDC, Brittain C, Cole M, Dewsnap C, et al
    Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
    Lancet. 2019 May 2. pii: S0140-6736(18)32817.
    PubMed     Abstract available


    April 2019
  101. THE LANCET
    Progress on investigating stillbirths.
    Lancet. 2019;393:1386.
    PubMed    


  102. DUHIG KE, Myers J, Seed PT, Sparkes J, et al
    Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
    Lancet. 2019 Apr 1. pii: S0140-6736(18)33212.
    PubMed     Abstract available


    March 2019
  103. THE LANCET
    Gestational diabetes in England: cause for concern.
    Lancet. 2019;393:1262.
    PubMed    


  104. WEI D, Liu JY, Sun Y, Shi Y, et al
    Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial.
    Lancet. 2019;393:1310-1318.
    PubMed     Abstract available


  105. LHEUREUX S, Gourley C, Vergote I, Oza AM, et al
    Epithelial ovarian cancer.
    Lancet. 2019;393:1240-1253.
    PubMed     Abstract available


  106. WATSON K
    Abortion as a moral good.
    Lancet. 2019;393:1196-1197.
    PubMed    


  107. LAUFER MK
    Beyond birthweight: benefits and risks of preventing malaria in pregnancy.
    Lancet. 2019 Mar 22. pii: S0140-6736(18)32615.
    PubMed    


  108. KAJUBI R, Ochieng T, Kakuru A, Jagannathan P, et al
    Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
    Lancet. 2019 Mar 22. pii: S0140-6736(18)32224.
    PubMed     Abstract available


  109. ZHAO F, Qiao Y
    Cervical cancer prevention in China: a key to cancer control.
    Lancet. 2019;393:969-970.
    PubMed    


    February 2019
  110. KLEBANOFF MA
    Interpregnancy interval after stillbirth: modifiable, but does it matter?
    Lancet. 2019 Feb 28. pii: S0140-6736(18)32430.
    PubMed    


  111. REGAN AK, Gissler M, Magnus MC, Haberg SE, et al
    Association between interpregnancy interval and adverse birth outcomes in women with a previous stillbirth: an international cohort study.
    Lancet. 2019 Feb 28. pii: S0140-6736(18)32266.
    PubMed     Abstract available


  112. KIOKO PM, Meana PR
    Abortion in Argentina.
    Lancet. 2019;393:745.
    PubMed    


  113. GARCIA G
    Abortion in Argentina.
    Lancet. 2019;393:744.
    PubMed    


  114. UZOIGWE CE
    Abortion in Argentina.
    Lancet. 2019;393:744-745.
    PubMed    


  115. OVADIA C, Seed PT, Sklavounos A, Geenes V, et al
    Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
    Lancet. 2019 Feb 14. pii: S0140-6736(18)31877.
    PubMed     Abstract available


  116. PALMER KR, Xiaohua L, Mol BW
    Management of intrahepatic cholestasis in pregnancy.
    Lancet. 2019 Feb 14. pii: S0140-6736(18)32323.
    PubMed    


  117. REPPING S
    Evidence-based medicine and infertility treatment.
    Lancet. 2019;393:380-382.
    PubMed    


  118. MILLER D, Pavitt S, Sharma V, Forbes G, et al
    Physiological, hyaluronan-selected intracytoplasmic sperm injection for infertility treatment (HABSelect): a parallel, two-group, randomised trial.
    Lancet. 2019;393:416-422.
    PubMed     Abstract available


    January 2019
  119. HOFMEYR GJ, Betran AP, Singata-Madliki M, Cormick G, et al
    Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial.
    Lancet. 2019;393:330-339.
    PubMed     Abstract available


  120. BUJOLD E, Hyett J
    Calcium supplementation for prevention of pre-eclampsia.
    Lancet. 2019;393:298-300.
    PubMed    


  121. COHEN PA, Jhingran A, Oaknin A, Denny L, et al
    Cervical cancer.
    Lancet. 2019;393:169-182.
    PubMed     Abstract available


  122. THE LANCET
    Cervical cancer: unequal progress.
    Lancet. 2019;393:104.
    PubMed    


    December 2018
  123. BERNITZ S, Dalbye R, Zhang J, Eggebo TM, et al
    The frequency of intrapartum caesarean section use with the WHO partograph versus Zhang's guideline in the Labour Progression Study (LaPS): a multicentre, cluster-randomised controlled trial.
    Lancet. 2018 Dec 20. pii: S0140-6736(18)31991.
    PubMed     Abstract available


  124. DIAZ-GARCIA C, Pellicer A
    Uterus transplantation from a deceased donor.
    Lancet. 2018 Dec 4. pii: S0140-6736(18)32106.
    PubMed    


  125. EJZENBERG D, Andraus W, Baratelli Carelli Mendes LR, Ducatti L, et al
    Livebirth after uterus transplantation from a deceased donor in a recipient with uterine infertility.
    Lancet. 2018 Dec 4. pii: S0140-6736(18)31766.
    PubMed     Abstract available


    November 2018
  126. THE LANCET
    Addressing preventable stillbirth and brain injury.
    Lancet. 2018;392:2238.
    PubMed    


    October 2018
  127. FARQUHAR C
    Unexplained infertility - Authors' reply.
    Lancet. 2018;392:1517.
    PubMed    


  128. GLEICHER N, Kuhnir VA, Barad DH
    Unexplained infertility.
    Lancet. 2018;392:1516-1517.
    PubMed    


  129. HOCKING JS, Temple-Smith M, Guy R, Donovan B, et al
    Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial.
    Lancet. 2018;392:1413-1422.
    PubMed     Abstract available


  130. ADAMSON PC, Klausner JD
    No benefit of chlamydia screening in primary care?
    Lancet. 2018;392:1381-1383.
    PubMed    


  131. SUBTIL D, Brabant G, Tilloy E, Devos P, et al
    Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)31617.
    PubMed     Abstract available


  132. KLEBANOFF MA, Brotman RM
    Treatment of bacterial vaginosis to prevent preterm birth.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)32115.
    PubMed    


    September 2018
  133. TEMMERMAN M, Lawn JE
    Stillbirths count, but it is now time to count them all.
    Lancet. 2018 Sep 27. pii: S0140-6736(18)32342.
    PubMed    


  134. SMITH LK, Hindori-Mohangoo AD, Delnord M, Durox M, et al
    Quantifying the burden of stillbirths before 28 weeks of completed gestational age in high-income countries: a population-based study of 19 European countries.
    Lancet. 2018 Sep 27. pii: S0140-6736(18)31651.
    PubMed     Abstract available


    August 2018
  135. GRESSLER LE, Titus-Glover D, Shaya FT
    Treatment modalities for pregnant women with opioid use disorder.
    Lancet. 2018;392:551.
    PubMed    


  136. SEN A, Nashef L
    New regulations to cut valproate-exposed pregnancies.
    Lancet. 2018;392:458-460.
    PubMed    


    July 2018
  137. GHOSN J, Taiwo B, Seedat S, Autran B, et al
    HIV.
    Lancet. 2018 Jul 23. pii: S0140-6736(18)31311.
    PubMed     Abstract available


  138. THE LANCET
    Cervical cancer prevention in Thailand-a model of success.
    Lancet. 2018;392:2.
    PubMed    


    June 2018
  139. LI A
    From Ireland to Northern Ireland: campaigns for abortion law.
    Lancet. 2018;391:2403-2404.
    PubMed    


  140. BOOTH A
    Argentina votes on bill to legalise abortion up to 14 weeks.
    Lancet. 2018;391:e21-e22.
    PubMed    


  141. THE LANCET
    Dolutegravir for HIV: a lesson in pregnancy safety research.
    Lancet. 2018;391:2296.
    PubMed    


    May 2018
  142. HALLGARTEN L
    Abortion narratives: moving from statistics to stories.
    Lancet. 2018 May 8. pii: S0140-6736(18)31036.
    PubMed    


  143. SPERBER A
    El Salvador's total ban on abortion risks women's health.
    Lancet. 2018;391:1758-1759.
    PubMed    


    April 2018
  144. BARNETT R
    Syphilis.
    Lancet. 2018;391:1471.
    PubMed    


    March 2018
  145. THE LANCET
    Diagnosis of heavy menstrual bleeding: a change in direction.
    Lancet. 2018;391:1122.
    PubMed    


  146. THE LANCET
    Abortion: access and safety worldwide.
    Lancet. 2018;391:1121.
    PubMed    


  147. WATTS G
    New York Challenge sets high bar for HPV vaccination.
    Lancet. 2018;391:1137.
    PubMed    


    February 2018
  148. MUSALLAM R, Salem N, Al Halol R, Al Deeb H, et al
    Management of pregnancy loss in the first trimester: a retrospective audit.
    Lancet. 2018;391 Suppl 2:S34.
    PubMed     Abstract available


  149. HABABEH M, Zeidan W, El-Kader MA, Thaher AA, et al
    Contraceptive use by Palestine refugee mothers of young children attending UNRWA clinics: a cross-sectional follow-up study.
    Lancet. 2018;391 Suppl 2:S26.
    PubMed     Abstract available


  150. KATEEB E, Momany E
    Factors related to high dental caries experience in Palestinian pregnant women in the Jerusalem governorate: a cross-sectional study.
    Lancet. 2018;391 Suppl 2:S11.
    PubMed     Abstract available


  151. LARSON HJ
    A global girl gang.
    Lancet. 2018;391:527-528.
    PubMed    


  152. DEVI S
    FGM in Sierra Leone.
    Lancet. 2018;391:415.
    PubMed    


    December 2017
  153. WEISS NS, Nahuis MJ, Bordewijk E, Oosterhuis JE, et al
    Gonadotrophins versus clomifene citrate with or without intrauterine insemination in women with normogonadotropic anovulation and clomifene failure (M-OVIN): a randomised, two-by-two factorial trial.
    Lancet. 2017 Dec 19. pii: S0140-6736(17)33308.
    PubMed     Abstract available


  154. CAHILL N, Sonneveldt E, Stover J, Weinberger M, et al
    Modern contraceptive use, unmet need, and demand satisfied among women of reproductive age who are married or in a union in the focus countries of the Family Planning 2020 initiative: a systematic analysis using the Family Planning Estimation Tool.
    Lancet. 2017 Dec 4. pii: S0140-6736(17)33104.
    PubMed     Abstract available


  155. KVASKOFF M, Horne AW, Missmer SA
    Informing women with endometriosis about ovarian cancer risk.
    Lancet. 2017;390:2433-2434.
    PubMed    


    November 2017
  156. GHORANI E, Kaur B, Fisher RA, Short D, et al
    Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia.
    Lancet. 2017;390:2343-2345.
    PubMed    


  157. NANDI A, El-Toukhy T
    Stimulated intrauterine insemination for unexplained subfertility.
    Lancet. 2017 Nov 23. pii: S0140-6736(17)33038.
    PubMed    


  158. FARQUHAR CM, Liu E, Armstrong S, Arroll N, et al
    Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial.
    Lancet. 2017 Nov 23. pii: S0140-6736(17)32406.
    PubMed     Abstract available


  159. KENDLER DL, Marin F, Zerbini CAF, Russo LA, et al
    Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
    Lancet. 2017 Nov 9. pii: S0140-6736(17)32137.
    PubMed     Abstract available


  160. MABEY D, Marks M, Peeling R, Lawn J, et al
    Stillbirth caused by syphilis remains a major global health problem.
    Lancet. 2017;390:2036.
    PubMed    


  161. HEININGER U
    Syphilis in children.
    Lancet. 2017;390:2035-2036.
    PubMed    


    October 2017
  162. REGAN L, Glasier A
    The British 1967 Abortion Act-still fit for purpose?
    Lancet. 2017;390:1936-1937.
    PubMed    


  163. YIN Y
    HPV vaccination in China needs to be more cost-effective.
    Lancet. 2017;390:1735-1736.
    PubMed    


    September 2017
  164. CASASSUS B
    Contraception implant removed from global market.
    Lancet. 2017;390:1576.
    PubMed    


  165. GEMZELL-DANIELSSON K, Cleeve A
    Estimating abortion safety: advancements and challenges.
    Lancet. 2017 Sep 27. pii: S0140-6736(17)32135.
    PubMed    


  166. GANATRA B, Gerdts C, Rossier C, Johnson BR Jr, et al
    Global, regional, and subregional classification of abortions by safety, 2010-14: estimates from a Bayesian hierarchical model.
    Lancet. 2017 Sep 27. pii: S0140-6736(17)31794.
    PubMed     Abstract available


  167. GARG SK, Polsky S
    Continuous glucose monitoring in pregnant women with type 1 diabetes.
    Lancet. 2017 Sep 14. pii: S0140-6736(17)32449.
    PubMed    


  168. FEIG DS, Donovan LE, Corcoy R, Murphy KE, et al
    Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
    Lancet. 2017 Sep 14. pii: S0140-6736(17)32400.
    PubMed     Abstract available


  169. DIZON DS
    PARP inhibitors for targeted treatment in ovarian cancer.
    Lancet. 2017 Sep 12. pii: S0140-6736(17)32418.
    PubMed    


  170. COLEMAN RL, Oza AM, Lorusso D, Aghajanian C, et al
    Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet. 2017 Sep 12. pii: S0140-6736(17)32440.
    PubMed     Abstract available


  171. DENNY L
    Nine-valent human papillomavirus vaccine: great science, but will it save lives?
    Lancet. 2017 Sep 5. pii: S0140-6736(17)32144.
    PubMed    


  172. HUH WK, Joura EA, Giuliano AR, Iversen OE, et al
    Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
    Lancet. 2017 Sep 5. pii: S0140-6736(17)31821.
    PubMed     Abstract available


    July 2017
  173. BANERJEE S
    Bevacizumab in cervical cancer: a step forward for survival.
    Lancet. 2017 Jul 27. pii: S0140-6736(17)31965.
    PubMed    


  174. TEWARI KS, Sill MW, Penson RT, Huang H, et al
    Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
    Lancet. 2017 Jul 27. pii: S0140-6736(17)31607.
    PubMed     Abstract available


    April 2017
  175. THE LANCET
    Syphilis: an ancient disease in a modern era.
    Lancet. 2017;389:1492.
    PubMed    


    December 2016
  176. HOOK EW RD
    Syphilis.
    Lancet. 2016 Dec 16. pii: S0140-6736(16)32411.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: